Role of Oral Selenium in Treatment of Respiratory Infections in Children.
Not Applicable
- Conditions
- Health Condition 1: J22- Unspecified acute lower respiratory infection
- Registration Number
- CTRI/2023/04/051842
- Lead Sponsor
- Rubeena Shaikh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients of age group 6 months to 5 years, admitted with acute lower respiratory tract infections fulfilling any three of the following eligibility criteria will be enrolled :
1.fever and/or cough,
2.tachypnea for age :respiratory rate: 6months to 12 months >50/min,
13 months to 5 years >40/min.,
3.accessory muscle use
4.wheeze and/or crepitation on auscultation.
Exclusion Criteria
All patients with
1.Severe acute malnutrition
2.Congenital heart disease
3.Chronic systemic illness
4.Gastrointestinal malformations
5.Patients on Micronutrient supplementation containing selenium
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study the time required for clinical recovery (defined as resolution of fever, absence of signs of respiratory distress, acceptance of oral feeds equivalent to pre-illness intake. <br/ ><br>2.To determine the duration,FiO2 requirement and mode of oxygen delivery (ventilation, CPAP, nonrebreathing mask, facemask, nasal prongs).Timepoint: 5 days or discharge (whichever is earlier)
- Secondary Outcome Measures
Name Time Method 1.To document the duration of hospital stay.2. To study the side effect of selenium(if any).Timepoint: 5 days or discharge (whichever is earlier)